Amylyx Pharmaceuticals, Inc.
AMLX
$32.40
-$1.48-4.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.67% | 37.10% | 79.59% | 46.76% | -41.63% |
| Total Receivables | 63.40% | -83.34% | -65.63% | -86.60% | -92.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -57.05% | -78.11% | -47.48% | 0.26% | -7.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 37.16% | 31.87% | 70.86% | 44.08% | -42.80% |
|
|
|||||
| Total Current Assets | 37.16% | 31.87% | 70.86% | 44.08% | -42.80% |
| Net Property, Plant & Equipment | -24.24% | 145.80% | 100.99% | 66.57% | 47.50% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 140.25% | 138.77% | 136.94% | 81.12% | 21.12% |
| Total Assets | 35.95% | 33.65% | 71.79% | 44.68% | -41.41% |
|
|
|||||
| Total Accounts Payable | 67.97% | -26.63% | 19.73% | 259.05% | -33.52% |
| Total Accrued Expenses | -16.35% | -6.51% | -25.22% | -61.41% | -72.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 51.58% | 9.48% | -17.06% | -50.25% | -71.93% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.28% | -10.96% | -20.13% | -52.16% | -69.43% |
|
|
|||||
| Total Current Liabilities | -1.28% | -10.96% | -20.13% | -52.16% | -69.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.82% | 1,268.81% | 914.69% | 732.61% | 586.14% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -4.95% | 11.96% | -5.14% | -43.60% | -62.29% |
|
|
|||||
| Common Stock & APIC | 26.30% | 26.26% | 36.90% | 37.26% | 12.34% |
| Retained Earnings | -22.23% | -23.36% | -23.86% | -26.23% | -37.79% |
| Treasury Stock & Other | -96.55% | -- | 539.13% | 27.15% | 668.04% |
| Total Common Equity | 42.47% | 35.62% | 85.27% | 69.21% | -35.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.47% | 35.62% | 85.27% | 69.21% | -35.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.47% | 35.62% | 85.27% | 69.21% | -35.76% |
|
|
|||||